000			03873nam a22003495i 4500
999			_c80503 _d80503 _x1
001			80503
003			ES-MaUEC
005			20230202102625.0
007			cr nn 008mamaa
008			130806s2014 gw | s |||| 0|eng d
020			_a9783642390227
024	7		_a10.1007/978-3-642-39022-7 _2doi
040			_dES-MaUEC
050		4	_aRC394.C95 _bD453 2014
100	1		_aDel Brutto, Oscar H. _988745 _0Local
245	1	0	_aCysticercosis of the Human Nervous System _cby Oscar H. Del Brutto, Héctor H. García
260			_aBerlin, Heidelberg _bSpringer International Publishing _c2014
300			_a1 recurso en línea (IX, 140 p.) _b48 ilustraciones, 14 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_a1 Foreword -- 2 History of taeniasis and cysticercosis -- 3 Epidemiology of human cysticercosis: -- Cysticercosis in endemic regions -- Cysticercosis in travelers and non-endemic regions -- 4 Life cycle and biological characteristics of Taenia solium -- 5 Neuropathology of cysticercosis and evolutive stages of cysticerci -- 6 Immunopathogenesis of cysticercosis -- 7 Clinical manifestations of Parenchymal neurocysticercosis: -- Epilepsy -- Focal neurological deficits -- Cognitive decline and psychiatric alterations -- Increased intracranial pressure -- 8 Clinical manifestations of Extraparenchymal neurocysticercosis: -- Intraventricular NCC -- Cysticercosis of the Sylvian fissure and basal CSF cisterns -- Subarachnoid NCC of the convexity -- 9 Diagnosis of cysticercosis (and Taeniasis): -- Neuroimaging -- Immunological diagnosis -- Other exams -- Diagnosis of taeniasis -- Diagnostic criteria for neurocysticercosis -- 10 Management of neurocysticercosis: -- Cysticidal drugs (albendazole and praziquantel) Surgery -- 11 Control and perspectives for elimination. Â{uE000}
520			_aNeurocysticercosis (neural infection by larvae of Taenia solium) occurs when humans become intermediate hosts of the tapeworm Taenia solium after ingesting its eggs, usually directly from a Taenia carrier. Nowadays, the disease is the most common helminthic infection of the nervous system in humans, and a major cause of acquired epilepsy. It has long been endemic in developing countries of Latin America, sub-Saharan Africa, the Indian subcontinent, and Southeast Asia. Recently, however, mass migration from endemic to non-endemic areas and growth in overseas travel have resulted in an increase in the prevalence of cysticercosis in countries where it was formerly considered exotic. The introduction of modern neuroimaging and serologic techniques has improved the diagnosis of neurocysticercosis, and the development of potent cysticidal drugs has changed the prognosis of most affected patients. Nevertheless, much remains to be learned about this parasitic disease. This book provides a comprehensive and up-to-date review of the various aspects of cysticercosis of the nervous system that will be of interest to all who are involved in the care of patients with the disease. Epidemiology, neuropathology, immunopathogenesis, clinical manifestations, diagnosis, and management are all thoroughly discussed based on current evidence and practice.
650		7	_2embne _9185363 _aCerebro _xEnfermedades
700	1		_aGarcía, Héctor H. _988746 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-642-39022-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12882562 _b10-10-17 _c11-11-15
942			_2lcc _cLE
945			_aRC394.C95 D453 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11562389 _z06-04-17
988			_aEBSPRINGER
998			_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _ggw _h0